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SUMMARY
The neural crest is a multipotent stem cell-like population that is induced during gastrulation, but
only acquires its characteristic morphology, migratory ability and gene expression profile after
neurulation. This raises the intriguing possibility that precursors are actively maintained by
epigenetic influences in a stem cell-like state. Accordingly, we report that dynamic histone
modifications are critical for proper temporal control of neural crest gene expression in vivo. The
histone demethylase, JumonjiD2A (JmjD2A/KDM4A), is expressed in the forming neural folds.
Loss of JmjD2A function causes dramatic down-regulation of neural crest specifier genes
analyzed by multiplex NanoString and in situ hybridization. Importantly, in vivo chromatin
immunoprecipitation reveals direct stage-specific interactions of JmjD2A with regulatory regions
of neural crest genes, and associated temporal modifications in methylation states of lysine
residues directly affected by JmjD2A activity. Our findings show that chromatin modifications
directly control neural crest genes in vertebrate embryos via modulating histone methylation.
INTRODUCTION
The neural crest (NC) is a multipotent stem cell-like population that migrates extensively
and differentiates into diverse cell types in vertebrate embryos. In the chick embryo, neural
crest induction initiates during gastrulation (Basch et al., 2006), leading to establishment of
a precursor population at the border between presumptive neural and non-neural ectoderm.
As the neural folds elevate (stage 7), these border cells begin to express premigratory neural
crest markers. Finally, after neural tube closure (stages 8–10), these cells become distinct
and emigrate from the central nervous system, migrating extensively and forming numerous
derivatives (Crane and Trainor, 2006; Knecht and Bronner-Fraser, 2002).
A “hard-wired” gene regulatory network, formulated from data derived from several model
vertebrates, is thought to mediate neural crest formation (Sauka-Spengler and Bronner-
Fraser, 2008). Most notably, modules of transcription factors are proposed to function in
sequential fashion to first specify the neural plate border and then the nascent neural crest.
Finally, the process of neural crest differentiation involves the activity of NC specifier genes
including SoxE transcription factors (Sox10 and Sox9), which regulate effector genes that
imbue neural crest derivatives with characteristics of terminal differentiation (Sauka-
Spengler and Bronner-Fraser, 2008). However, little is known about the hierarchical
relationships, direct regulatory interactions, or connections between these different modules.
The temporal gap between initial induction during gastrulation (Basch et al., 2006) and final
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appearance of the migratory, multipotent neural crest raises the fundamental question of
what maintains neural crest cells in an undifferentiated, stem cell-like state in the
intervening time.
The prolonged maintenance of stem cell properties is consistent with an important role for
chromatin modifications in spatiotemporal control of the neural crest gene expression
program. In vitro studies of embryonic stem cells suggest that these modification events may
poise stem cell genes in a transcriptionally ready state via modifications of N-terminal
histone tails. For example, histone methylation has been associated with both transcriptional
activation and repression (Kouzarides, 2007). Whereas methylation of H3 lysines 4 and 36
(H3K4me2/me3 and H3K36me2/3) are enriched in transcriptionally active euchromatic
regions, H3 lysines 9 and 27 (H3K9me3 and H3K27me3) are located in repressed sites
(Nielsen et al., 2001; Shi et al., 2003) as well as associated with heterochromatin (Li et al.,
2007; Nakayama et al., 2001; Peters et al., 2002). Histone demethylases such as members of
the Jumonji family revert histone trimethylation (Tan et al., 2007). Unlike other
demethylases, JmjD2/KDM4 proteins have been shown to remove both lysine 9 and 36
trimethyl marks (Couture et al., 2007).
An intriguing possibility is that such chromatin modifiers may play a critical role in the
balance between differentiation and stem cell like behavior at the neural plate border and
forming neural crest. However, little is known about the function of the Jumonji family or
other epigenetic modifiers in vivo in the developing vertebrate embryo. As an accessible
embryonic stem cell population, the neural crest offers an excellent experimental system to
probe the role of chromatin modification during development in vivo.
RESULTS
Jumonji is expressed at key times/locations during neural crest development
The JmjD2/KDM4 subfamily consists of the JmjD2A-F genes, though JmjD2E and F appear
to be pseudogenes (Katoh, 2004) and only the JmjD2A-D proteins possess histone
demethylase activity (Cloos et al., 2006; Klose et al., 2006; Whetstine et al., 2006). By in
silico analysis, only JmjD2A-C genes were detectable in the chick genome.
We examined the presence of all three transcripts by whole mount in situ hybridization and
quantitative polymerase chain reaction (QPCR) from chick gastrulation through neural crest
migration (Fig. 1, S1). Of these, JmjD2A demonstrated appropriate spatiotemporal
expression consistent with playing a role in neural crest development (Fig. 1A–G). JmjD2A
transcripts were observed in the neural plate, neural plate border and non-neural ectoderm
(Fig. 1A–C). JmjD2A initially is expressed throughout the neural plate, partially overlapping
with the neural plate border marker Pax7 (Basch et al., 2006), but resolves to the neural crest
forming region by stage 5/6. As the neural folds elevate, JmjD2A was restricted to the dorsal
neural folds, from which neural crest cells originate, as well as faintly expressed in non-
neural ectoderm (Fig. 1D–E). Protein expression, as revealed by a JmjD2A specific
antibody, paralleled that of the transcripts (Fig. 1G). After neural tube closure, only low
levels of JmjD2A expression were observed on migrating HNK1+ neural crest cells (Fig.
1F). Parallel analysis by QPCR reveals the highest expression of JmjD2A at stage 5,
decreasing from stage 8 onward; this is reciprocal to the onset of Sox10 expression, a key
regulator of neural crest cell specification (Fig. 1H). In contrast to JmjD2A, JmjD2B was
detected only by QPCR presenting an invariable patter of expressing (Fig. 1H), and JmjD2C
was not detectable by either QPCR or in situ hybridization at the stages examined (Fig. S1).
These data provide anatomical and temporal evidence suggesting that JmjD2A may be an
important player in neural crest specification.
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Over-expression of JmjD2A in fibroblasts specifically depletes H3K9me3 and H3K36me3
To define the lysine specificity of chick JmjD2A, a vector containing the coding sequence of
JmjD2A (JmjD2A-GFP) under the control β-actin promoter was transfected into chicken
fibroblast cells (Fig. S2). The results show that cells over-expressing JmjD2A completely
lack either H3K9me3 or H3K36me3 marks; and on the other hand, H3K27me3 methylation
marks remain expressed. This activity is dependent on an intact JmjC domain, as amino-acid
substitutions (ΔJmjD2A-GFP: G133A, G138A, G165A, G170A, S288N and T289B) in the
catalytic domain (Chen et al., 2007) abrogate these effects. These results demonstrate that
JmjD2A is specific for H3K9me3 and H3K36me3 substrates in these cells, consistent with
previous reports.
Loss of JmjD2A leads to depletion of neural crest specifier genes
To examine the function of JmjD2A in neural crest specification, we tested its
developmental effects on gene expression by a loss-of-function analysis using antisense
morpholino oligonucleotides (MO) to specifically block translation of JmjD2A protein. We
used two non-overlapping fluorescein-tagged MOs, one located just over the ATG codon
and the second l38 nucleotides upstream of the start codon, with both yielding similar
effects. MOs plus carrier DNA were injected on the left half of stage 4–5 embryos, such that
the uninjected side served as an internal control. Immunoblotting confirmed a marked
reduction of JmjD2A protein after morpholino knock-down on the injected side (IS)
compared with the uninjected side (UIS) of the same embryos, as well as between the
injected side of control-MO treated embryos (Fig. 3C). Furthermore, there was no
significant change in either cell proliferation (P = 0.29, n = 5) or cell death (P = 0.32, n = 5),
as assayed by TUNEL and phosphohistone 3 staining (Fig. S4B).
As a first step in assessing the effects of JmjD2A on a wide array of downstream genes, we
used the NanoString nCounter technology (Fortina and Surrey, 2008) to perform a multiplex
analysis to examine changes in transcript levels of 50 genes (Fig. 2, S3), including those
expressed in the neural crest, neural plate, neural plate border, neural tube, ectodermal
placodes and non-neural ectoderm, as well as genes involved in proliferation and apoptosis.
Individual half embryos (injected versus non-injected side) were analyzed at st. 6 or st. 9
after treatment with JmjD2A- or control-MO (Fig. 2). No significant differences were
observed at either stage between the two sides of control-MO treated embryos (Fig. 2B, C),
with a less than 20% variation. As a consequence, we defined 25% (gray dotted line on
figure 2) variation as our cut-off for statistical significance. At stage 6, the NanoString reads
collected from four embryos showed that JmjD2A-MO caused a down-regulation of only the
Sox8 (P=0.04) gene (inset in Fig. 2A). However, by stage 9, there was a significant
reduction in gene expression for several neural crest specifier genes, with Sox10 (P=0.0002)
most dramatically affected, as well as significant down-regulation of Sox8 (P=0.04), FoxD3
(P=0.04), Snail2 (P=0.02) and Wnt1 (P=0.01). Twist1 (P=0.03) was the only gene
significantly up-regulated (inset in Fig. 2C) after JmjD2A knock-down. In contrast, there
were no significant changes in the expression of several neural tube, ectodermal, neural plate
and border genes, or in markers of proliferation and apoptosis.
In order to corroborate the NanoString nCounter results and gain spatial information on
expression on some of the genes affected by the JmjD2A-MO treatment, we perfomed in
situ hybridization (Fig. 3A–B, 4). The results show that JmjD2A protein knock-down
profoundly diminishes expression of neural crest specifier genes while having no effect on
other genes in the neural tube. By categorizing embryos according to the severity of their
phenotype as strong, mild or none (Fig. S4A), we observed significant reduction between
morpholino-treated and control embryos in the expression of neural crest specifier genes
Sox10 (P<0.01, n = 22), Sox9 (P<0.01, n = 9), FoxD3 (P<0.05, n = 6) and Snail2 (P<0.05, n
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= 8) in pre-migratory and migratory neural crest cells. On the other hand, we observed no
significant effects on expression in the dorsal neural tube of Pax7, Msx1 and Sox2 (n = 6).
As expected, control-MO treated embryos had no phenotype. These results are consistent
with those observed in our NanoString experiments, with the addition of the neural crest
specifier gene Sox9, for which we lacked a functional NanoString probe.
To control for the specificity of our morpholino knock-down, rescue experiments were
performed by co-electroporating the JmjD2A-MO, located upstream of the start codon, with
a vector encoding full length JmjD2A protein (JmjD2A-H2RFP), plus nuclear RFP
expressed as an independent protein due to the presence of an Internal Ribosome Entry Site
(IRES) in the vector (Fig. 5). Co-electroporation of JmjD2A-MO plus JmjD2A-H2RFP
resulted in a 25% reduction in the severity of the phenotype compared with co-
electroporation of JmjD2A-MO plus empty vector (H2RFP), and was not significantly
different from control-MO treated embryos. Importantly, the rescue effect was lost when the
morpholino was co-electroporated with the mutated JmjD2A lacking catalytic activity
(ΔJmjD2A-H2RFP) described above, restoring significant differences (P<0.01) from
phenotypes observed in control-MO treated embryos.
To look at long-term effect of the JmjD2A depletion, we examined the formation of ganglia
in the head to which the neural crest contributes (trigeminal, geniculate, petrosal and
nodose) formation (Fig. S5). The results reveal a severe defect in the cranial ganglia
formation as assayed by β-neurotubulin (TuJ1) immunostaining at St. 16–17. This is
particularly evident in the trigeminal ganglion, the largest of the cranial ganglia, which
appears smaller and ill-formed on the injected side of JmjD2A-MO treated embryos
compared with both the self uninjected side of the same embryo or with control-MO treated
embryos.
Taken together, these results demonstrate that JmjD2A is required and remarkably specific
for correct expression of several neural crest specifier genes, perturbation of which causes
profound defects in neural crest derivatives. This highlights the importance of chromatin
modifications during neural crest development.
H3K9me3 and H3K36me3 occupancy regulates neural crest specifier expression in vivo
In order to directly determine the importance of histone methylation in regulation of NC
specifier gene expression, we performed chromatin immunoprecipitation (ChIP) with
antibodies to H3K9me3 and H3K36me3 using dissected tissue from 30 embryos. The results
reveal dynamic occupancy of sites in proximity to the transcriptional start site (TSS) of two
important neural crest specifier genes, Sox10 and Snail2 (Fig. 6A).
Tissue was dissected from embryonic regions containing neural crest precursors from
gastrula stage (stages 3–4) or from actively migrating stages (stages 10–11). Interestingly,
we observed high and moderate occupancy of H3K9me3 at −0.5kb from the TSS of the both
Sox10 and Snail2 at the late gastrula stage, respectively. This result is consistent with the
possibility that this strong epigenetic repression mark inhibits transcription at this time point.
Moreover, occupancy of H3K36m3, generally associated with active gene transcription, was
high for the β-actin and Snail2, and low for Sox10. Taken together, the location and
abundance of H3K9me3 and H3K36me3 clearly reflects the transcriptional state of a
repressed Sox10, Snail2 poised for activation and active β-actin gene at late gastrula stages.
Interestingly, the occupancy of the “repressive” mark H3K9me3 near the Sox10 and Snail2
TSS was clearly reduced by times of active neural crest migration (stages 10–11) and
approached levels similar to those observed for β-actin, consistent with high expression of
these genes by this stage. On the other hand, occupancy on the H3K36me3 marks situated
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downstream of the TSS was still abundant for Snail2 and β-actin loci, but unchanged in
Sox10. These findings suggest that the demethylation of H3K9me3 (repressive) marks plays
an important role in regulating expression of neural crest specifier genes during chick
development.
JmjD2A directly binds to regulatory regions of neural crest specifier genes in vivo
We next performed ChIP for JmjD2A as a function of developmental stages using dissected
tissue from 30 embryos and analyzing by QPCR the occupancy around the TSS of Sox10,
Snail2 and β-actin genes (Fig. 6B, S6). Interestingly, JmjD2A ChIP revealed stage
dependent binding to a regulatory region located −0.5kb from the TSS of both Sox10 and
Snail2 neural crest specifier genes. During gastrulation, there was 2.6 and 4 fold changes on
the input enrichment near the Sox10 and Snail2 TSS region, respectively, relative to
negative controls situated in ORF-free intergenic regions on the same chromosome, Chr1
(negative control for Sox10), Chr2 (negative control for Snail2). Moreover, no differences
were observed when analyzing similar positions on the β-actin locus. In contrast to
gastrulation, we failed to detect occupancy of JmjD2A around the TSS of the Sox10, Snail2
and β-actin genes during neural crest migration less than one day later. These data
demonstrate that JmjD2A interacts in vivo in a time and location dependent manner on
neural crest specifier genes, Sox10 and Snail2. Interestingly, the direct interaction of
JmjD2A with neural crest regulatory regions correlates well with the histone modifications
described in the figure 5, consistent with the idea that it derepresses those genes through
H3K9me3 demethylation.
JmjD2A knock-down inhibits demethylation of H3K9me3 on the Sox10 promoter
To narrow the timing of JmjD2A action on neural crest genes, we performed ChIP with
H3K9me3 and JmjD2A antibodies using dorsal neural tubes from embryos collected at stage
8 and 9 in order to explore when H3K9me3 is demethylated and how the timing correlates
with binding of JmjD2A to the Sox10 promoter. The time period between stage 8 and 9 is
key because it correlates with the first appearance of Sox10 transcripts in the neural crest by
both in situ hybridization and quantitative PCR. The results reveal a fine time window of
association between the JmjD2A and H3K9me3 occupancy on the Sox10 promoter (Fig. 7A,
B). Interestingly, JmjD2A binds efficiently to −0.5kb on Sox10 genes at St. 8, but not at St.
9 by which time its association is not different from the negative control region (Chr1 nc). In
a similar manner, the region −0.5Kb from the TSS of Sox10 gene was highly occupied by
H3K9me3 at St. 8, but dropped precipitously at stage 9 to levels comparable to those
observed on surrounding region (−1 and 0.5Kb from the TSS). These results reveal a rapid
and dynamic process whereby JmjD2A is preloaded on the Sox10 locus and leaves upon
demethylation, thus permitting activation of Sox10 transcription.
Given the dynamic changes in both JmjD2A and H3K9me3 occupancy of the Sox10
promoter between stages 8 and 9, we examined the effects of JmjD2A-MO on Sox10
promoter occupancy at these key stages (Fig 7C, D). As predicted, the occupancy JmjD2A
was completely abolished on the promoter in JmjD2A-MO compared with both control-MO
and untreated embryos collected at stage 8. This is not surprising given the lack of JmjD2A
protein in the JmjD2-MO embryos. On the other hand, H3K9me3 occupancy of the Sox10
promoter clearly increased in JmjD2A-MO treated embryos collected at stage 9, with
highest levels at −0.5kb from the TSS. In contrast, control-MO embryos had similar levels
at all positions analyzed, scoring values similar to those observed on untreated embryos at
stage 9. As a further control, we use −0.5Kb from the TSS of β-actin gene, and observed no
differences in H3K9me3 association between JmjD2A-MO and control-MO treated embryos
(Fig. 7E). These results conclusively demonstrate that JmjD2A activity is responsible for
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demethylation of H3K9me3 at −0.5kb from the TSS of Sox10 gene which in turn
derepresses expression of Sox10 transcripts.
DISCUSSION
Jumonji family members have been shown to function as powerful regulators of epigenetic
events in cell culture (Nottke et al., 2009). However, little has been known about their roles
and mechanism of action in the context of the whole organism. In the present work, we
demonstrate that the Jumonji family member, JmjD2A, is critical for embryonic
development, playing a specific role in allowing neural crest gene expression at the
appropriate developmental time. This dramatic stage-dependent regulation of gene
expression is made possible due to appropriate histone modifications. Thus, Jumonji
dependent chromatin modification can be used to dynamically regulate rapidly changing
gene regulatory networks such as the one underlying neural crest formation.
By specifically affecting the neural crest specifier module, our data place JmjD2A as a
modulator that functions upstream of neural crest specifier genes. However, there is an
intriguing delay between JmjD2A occupancy and reduction of H3K9me3 on the Sox10
locus, opening the possibility that other factors need to be recruited to the TSS. In this
critical position, JmjD2A acts on neural crest precursors that are retained in a stem cell-like
state but poised to initiate transcription upon removal of a repressive H3K9me3 mark. In this
way, neural crest cells that are induced during gastrulation only initiate a bona fide neural
crest program during neurulation.
Current thinking regarding the histone code involved in controlling differential methylation
states suggests that H3K9me3 is linked to “silent” genes or pericentric heterocromatin
(Peters et al., 2002), whereas H3K36me3 is linked to transcriptional elongation (Li et al.,
2007) and suppression of inappropriate transcription (Carrozza et al., 2005; Keogh et al.,
2005). Furthermore, H3K36me3 is generally restricted to the coding region downstream for
the TSS, and is particularly enriched in exons. Our data suggest that the balance between
bivalent JmjD2A histone targets, H3K9me3 and H3K36me3, reflecting repressive and
activating marks respectively, may underlie the fine tuning that controls the timing of
execution of a neural crest gene regulatory network program in vivo. However even when
we observed high H3K36me3 occupancy at the 3′ region on actively transcribed genes (e.g.
Snail2 and β-actin), we failed to observe a similar pattern on the Sox10 gene at stages of
active transcription. An intriguing possibility in the case of Sox10 in neural crest cells is that
the normal role of H3K36me3 is replaced by another epigenetic mark that allows it
elongation, such as, H3K79me2 which also is associated with active transcription (Morillon
et al., 2005; Schubeler et al., 2004).
A similar bivalent regulation between repressive (H3K27me3) and activating (H3K4me3)
marks has been described in a large set of developmentally important genes in embryonic
stem cells in vitro. Moreover, the activation of some of these genes correlates well with the
demethylation of H3K27me3 (Azuara et al., 2006; Bernstein et al., 2006). These similarities
raise the possibility that the flavor of the histone mark may regulate the degree of a cell’s
multipotency. Genes that are repressed in multipotent cells contain distinct bivalent
H3K9me3/H3K36me3 marks that render them poised for activation, and are distinguishable
from those required for later differentiation genes. In fact, H3K9me3 and H3K36me3 marks
can discriminate between genes that are expressed (H3K36me3) or stably repressed
(H3K9me3). As a consequence, they may reflect the cell’s state and fate potential
(Mikkelsen et al., 2007). To date, it remains unknown whether JmjD2A favors H3K9me3 or
H3K36me3 sites in vivo. This opens the possibility that JmjD2A may form complexes with
different proteins depending upon its local and changing intracellular environment. A
Strobl-Mazzulla et al. Page 6
Dev Cell. Author manuscript; available in PMC 2011 September 14.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
similar scenario has been suggested previously for other demethylases (Metzger et al., 2005;
Shi et al., 2003).
Our observation that JmjD2A is associated with key neural crest specifier genes gives an
additional and dynamic level of complexity to the neural crest gene regulatory network
(Sauka-Spengler and Bronner-Fraser, 2008), emphasizing the importance of chromatin
modification in spatial and temporal control of gene expression during development
Furthermore, these findings highlight the intriguing possibility that repressive histone marks
influences may underlie the latency of the multipotent state of neural crest precursors
between induction and overt morphological manifestation of the mature state.
EXPERIMENTAL PROCEDURES
Embryos
Fertilized chicken eggs were obtained from local commercial sources and incubated at 37° C
to the desired stages according to the criteria of Hamburger and Hamilton. For in situ
hybridization (ISH), embryos were fixed overnight in 4% paraformaldehyde (PFA) at 4°C,
washed in PTW (PBS-DEPC treated containing 0.1% Tween) and dehydrated in a MeOH/
PTW series at room temperature before being stored at −20°C in 100% MeOH.
RNA preparation and QPCR
RNA was prepared from individual embryos (n=3) using RNAqueous®-Micro isolation kit
(Ambion) following manufacturers instruction. The obtained RNA was treated with DNaseI
amplification grade (Invitrogen) and then reversed-transcribed to cDNA with SuperScript III
(Invitrogen) using random hexamers. QPCR was performed using the 96-well plate ABI
7000 QPCR machine in a TaqMan assay (Applied Biosciences) with Sybrgreen Itaq
Supermix with ROX (Bio-Rad), 150–450 nM of each primer, and 200–500 ng of cDNA in a
25 μl reaction volume. During the exponential phase of the QPCR reaction, a threshold cycle
(CT) and baseline was set according to the protocols of Applied Biosystems. The results for
different samples were then interpolated on a line created by running standard curves for
each primer set and then normalized against the GADPH housekeeping gene. These
calculations were performed according to the standard curve assay method which is detailed
in the Applied Biosystems protocols. Three replicates of every sample and points of the
standard curve were loaded.
Electroporation of antisense morpholinos and vectors
Two antisense morpholinos to JmjD2A were designed, one near the ATG codon (5′-
TGAGGCTCTCCAGCTCCGAGGCCAT-3′) and the second located 38 nucleotides
upstream of the start codon (5′-CGGTCAGCTCCGCGTCCCGCTTCTT-3′), with both
yielding similar results. Injections of fluorescein-tagged morpholino (1 mM plus 0.3 mg/ml
of plasmid DNA) and pCIG -H2RFP, -JmjD2A-H2RFP and/or -ΔJmjD2A-H2RFP
(catalytically dead mutant carrying mutations on G133A, G138A, G165A, G170A, S288N
and T289B) vectors were performed by air pressure using a glass micropipette targeted to
the presumptive neural crest region at stages 4–5. Stages 4–5 electroporation was conducted
on whole chick embryo explants placed ventral side up on filter paper rings. The
morpholinos and vectors were injected on the left side of the embryo and platinum
electrodes were placed vertically across the chick embryos and electroporated with five
pulses of 7 V in 50 ms at 100 ms intervals. Embryos were cultured in 0.5 ml of albumen in
tissue culture dishes to reach the desired stages. Embryos were then removed and, fixed
overnight in 4% PFA at 4°C. Embryos were placed in PBS, viewed and photographed as
whole-mounts using a fluorescence stereomicroscope to evidence electroporation efficiency.
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Embryos used for ISH were dehydrated in a MeOH/PTW series at room temperature before
being stored at −20°C in 100% MeOH.
NanoString nCounter
Individual half of embryos treated with Control-MO and JmjD2A-MO were disaggregated
in lysis buffer (Ambion) and stored at −80°C. The total RNA from the lysates were then
allowed to hybridize with the capture and reporter probe and incubating overnight at 65°C
according to nCounter™ Gene Expression Assay Manual. After the washes, the purified
Target/Probe complexes were eluted off and immobilized in the cartridge for data collection
carried out in the nCounter™ Digital Analyzer.
In situ hybridization (ISH)
Whole-mount chick ISH was performed as previously described (Kee 2001). Linealized
plasmidic DNA templates used for digoxigenin-labeled RNA probes were JmjD2A,
JmjD2B, JmjD2C, Sox10, Sox9, FoxD3, Snail2, Pax7, Msx1, and Sox2. Embryos were
imaged as a whole-mount and after were transverse sectioned at 14–16 μm in a cryostat.
Cell death and proliferation
TUNEL labeling was performed using the TMR-In Situ Cell Death kit (Roche) and
subsequently immunostained with the proliferation marker Phosphohistone 3 (rabbit anti-
PH3, 1:500), and then detected using the secondary Alexa Fluor goat anti-rabbit 350
(1:1000). Cells were counted in the dorsal neural tube of both JmjD2A-MO and Control-
MO, and expressed as a ratio between injected vs. unijected side.
Chromatin immunoprecipitation (ChIP)
Cells were extracted from presumptive neural plates and dorsal-rostral area (see cartoon in
figure 4) from 30 embryos on three independent experiment at stages 3–4 and 10–11,
respectively. The cells were then cross-linked and sonicated in an average size of 300–800
bp. Samples were split into five tubes for Input sample, mock control (rabbit anti-IgG) and
target antibodies (anti-JmjD2A, anti-H3K9me3 and anti-H3K36me3, Abcam) bound to
Protein A-magnetic beads (Invitrogen). The complexes were magnetically isolated, eluted
and crosslink reversed. The DNA was purified, precipitated and finally used as a template
for QPCR analyzes (see table 1S for list of primers). Every sample was load by three
replicates each. The results were quantified using ΔΔCt method and calculated according to
manufacturer’s instructions (Applied BioSystems). On the ChIPs performed on
morpholinated treated embryos, 10 dorsal neural tube were dissected from JmjD2A-MO and
Control-MO embryos at stages 8 and 9, and processed as above mentioned
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We thank Dr. Scott Fraser for critical reading of the manuscript. This work was supported by USPHS grant
HD037105.
REFFERENCES
Azuara V, Perry P, Sauer S, Spivakov M, Jorgensen HF, John RM, Gouti M, Casanova M, Warnes G,
Merkenschlager M, et al. Chromatin signatures of pluripotent cell lines. Nat Cell Biol. 2006; 8:532–
538. [PubMed: 16570078]
Strobl-Mazzulla et al. Page 8
Dev Cell. Author manuscript; available in PMC 2011 September 14.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Basch ML, Bronner-Fraser M, Garcia-Castro MI. Specification of the neural crest occurs during
gastrulation and requires Pax7. Nature. 2006; 441:218–222. [PubMed: 16688176]
Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M,
Plath K, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem
cells. Cell. 2006; 125:315–326. [PubMed: 16630819]
Carrozza MJ, Li B, Florens L, Suganuma T, Swanson SK, Lee KK, Shia WJ, Anderson S, Yates J,
Washburn MP, et al. Histone H3 methylation by Set2 directs deacetylation of coding regions by
Rpd3S to suppress spurious intragenic transcription. Cell. 2005; 123:581–592. [PubMed: 16286007]
Chen Z, Zang J, Kappler J, Hong X, Crawford F, Wang Q, Lan F, Jiang C, Whetstine J, Dai S, et al.
Structural basis of the recognition of a methylated histone tail by JMJD2A. Proc Natl Acad Sci U S
A. 2007; 104:10818–10823. [PubMed: 17567753]
Cloos PA, Christensen J, Agger K, Maiolica A, Rappsilber J, Antal T, Hansen KH, Helin K. The
putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature. 2006;
442:307–311. [PubMed: 16732293]
Couture JF, Collazo E, Ortiz-Tello PA, Brunzelle JS, Trievel RC. Specificity and mechanism of
JMJD2A, a trimethyllysine-specific histone demethylase. Nat Struct Mol Biol. 2007; 14:689–695.
[PubMed: 17589523]
Crane JF, Trainor PA. Neural crest stem and progenitor cells. Annu Rev Cell Dev Biol. 2006; 22:267–
286. [PubMed: 16803431]
Fortina P, Surrey S. Digital mRNA profiling. Nat Biotechnol. 2008; 26:293–294. [PubMed: 18327237]
Katoh M. Identification and characterization of JMJD2 family genes in silico. Int J Oncol. 2004;
24:1623–1628. [PubMed: 15138608]
Keogh MC, Kurdistani SK, Morris SA, Ahn SH, Podolny V, Collins SR, Schuldiner M, Chin K, Punna
T, Thompson NJ, et al. Cotranscriptional set2 methylation of histone H3 lysine 36 recruits a
repressive Rpd3 complex. Cell. 2005; 123:593–605. [PubMed: 16286008]
Klose RJ, Yamane K, Bae Y, Zhang D, Erdjument-Bromage H, Tempst P, Wong J, Zhang Y. The
transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36.
Nature. 2006; 442:312–316. [PubMed: 16732292]
Knecht AK, Bronner-Fraser M. Induction of the neural crest: a multigene process. Nat Rev Genet.
2002; 3:453–461. [PubMed: 12042772]
Kouzarides T. Chromatin modifications and their function. Cell. 2007; 128:693–705. [PubMed:
17320507]
Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell. 2007; 128:707–719.
[PubMed: 17320508]
Metzger E, Wissmann M, Yin N, Muller JM, Schneider R, Peters AH, Gunther T, Buettner R, Schule
R. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent
transcription. Nature. 2005; 437:436–439. [PubMed: 16079795]
Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim
TK, Koche RP, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed
cells. Nature. 2007; 448:553–560. [PubMed: 17603471]
Morillon A, Karabetsou N, Nair A, Mellor J. Dynamic lysine methylation on histone H3 defines the
regulatory phase of gene transcription. Mol Cell. 2005; 18:723–734. [PubMed: 15949446]
Nakayama J, Rice JC, Strahl BD, Allis CD, Grewal SI. Role of histone H3 lysine 9 methylation in
epigenetic control of heterochromatin assembly. Science. 2001; 292:110–113. [PubMed:
11283354]
Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O’Carroll D, Firestein R, Cleary M,
Jenuwein T, Herrera RE, et al. Rb targets histone H3 methylation and HP1 to promoters. Nature.
2001; 412:561–565. [PubMed: 11484059]
Nottke A, Colaiacovo MP, Shi Y. Developmental roles of the histone lysine demethylases.
Development. 2009; 136:879–889. [PubMed: 19234061]
Peters AH, Mermoud JE, O’Carroll D, Pagani M, Schweizer D, Brockdorff N, Jenuwein T. Histone H3
lysine 9 methylation is an epigenetic imprint of facultative heterochromatin. Nat Genet. 2002;
30:77–80. [PubMed: 11740497]
Strobl-Mazzulla et al. Page 9
Dev Cell. Author manuscript; available in PMC 2011 September 14.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Sauka-Spengler T, Bronner-Fraser M. A gene regulatory network orchestrates neural crest formation.
Nat Rev Mol Cell Biol. 2008; 9:557–568. [PubMed: 18523435]
Schubeler D, MacAlpine DM, Scalzo D, Wirbelauer C, Kooperberg C, van Leeuwen F, Gottschling
DE, O’Neill LP, Turner BM, Delrow J, et al. The histone modification pattern of active genes
revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev. 2004;
18:1263–1271. [PubMed: 15175259]
Shi Y, Sawada J, Sui G, Affar el B, Whetstine JR, Lan F, Ogawa H, Luke MP, Nakatani Y.
Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature. 2003;
422:735–738. [PubMed: 12700765]
Tan H, Wu S, Wang J, Zhao ZK. The JMJD2 members of histone demethylase revisited. Mol Biol
Rep. 2007
Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z, Spooner E, Li E, Zhang G,
Colaiacovo M, et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone
demethylases. Cell. 2006; 125:467–481. [PubMed: 16603238]
Strobl-Mazzulla et al. Page 10
Dev Cell. Author manuscript; available in PMC 2011 September 14.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1. JmjD2A is expressed at the right time and location to play an important role in neural
crest development
(A–F) Expression pattern of JmjD2A in the early chick embryo by whole mount in situ
hybridization at stages 4–10. Transverse sections (dotted lines) reveal specific expression in
the neural plate at stage 5 (B′); in neural plate, neural plate border and non-neural ectoderm
at stage 6 (C′); in dorsal neural tube at stage 8 (E′); and at low levels in migratory neural
crest (evidenced by HNK-1 staining in red) at stage 10 (F′). (G) Immunohistochemistry
using an anti-JmjD2A corroborates the protein expression at stage 8 in dorsal neural tube
and non-neural ectoderm. (H) QPCR analyses show highest expression of JmjD2A (black
bars) at stage 5, decreasing thereafter in a manner reciprocal to that of the neural crest
specifier gene, Sox10 (solid line). JmjD2B (gray bars) present an invariable expression
patter during the analyzed stages. Values represent the average of 3 samples run in triplicate
± SD. See also Figure S1.
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Figure 2. NanoString nCounter quantification. JmjD2A loss-of-function affects neural crest
specifier gene expression
(A) At stage 6, the injected side of JmjD2A-MO treated embryos shows >25% reduction of
Sox8 (gray) on the injected compared with the uninjected side. No significant changes were
noted in other genes. (B) Control morpholino injected embryos had no significant
differences between injected and uninjected side at stage 6. (C) At stage 9, the expression of
several neural crest specifier genes, including Sox10 (red), FoxD3 (blue), Sox8 (gray) and
Snail2 (yellow), as well as the signaling factor, Wnt1 (pink) were reduced more than 25% on
the JmjD2A-MO injected side (IS) compared with the uninjected (UIS). In contrast, Twist1
(green) was upregulated on the morpholino-injected side. (D) Control morpholino injected
embryos had no significant differences between injected and uninjected side at stage 9.
Insets show fold expression differences (mean ± SD) between IS and UIS comparing
JmjD2A-MO (n=4) and control-MO (n=3) treated embryos. Asterisks (* and **) indicate
significant differences (P<0.05 and P<0.01, respectively) by t-Student test (B-D). Dotted
line represents variation greater than 25% between IS and UIS. See also Figure S3.
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Figure 3. JmjD2A loss-of-function depletes Sox10 expression
(A) Electroporation of fluorescent JmjD2A morpholino (JmjD2A-MO) into one side of the
embryo (green staining in inset) causes a dramatic reduction in Sox10 expression in embryos
examined at stage 8+ and 10, compared with the non-electroporated side or control
morpholinated embryos (Control-MO). (B) Quantitation of the numbers of JmjD2A-MO
treated embryos with either mild or strong phenotypes on the electroporated versus
contralateral side compared with those observed in control-MO treated embryos. Asterisk
indicates significant differences (P<0.01) by contingency table followed by chi-square test.
Numbers represent individual embryos. (C) Western blots reveal specific reduction of
JmjD2A protein expression on the JmjD2A-MO injected side (IS) compared with both the
uninjected side (UIS) and the injected side of the Control-MO embryos. See also Figure S4.
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Figure 4. JmjD2A loss-of-function affects expression of neural crest specifier genes Sox9, FoxD3
and Snail2, but not dorsal neural tube markers
As seen by in situ hybridization in whole mount (A–F) or transverse section (bottom of each
panel) (A′–F′), electroporation of JmjD2A-MO causes a significant reduction in expression
of Sox9, FoxD3 and Snail2, whereas no obvious effects were noted for Pax7, Sox2 and
Msx1. Insets show the distribution of fluorescently labeled morpholino (green). Dotted lines
indicate level of section. (G) Quantitation of the numbers of embryos showing a phenotype
on the electroporated side of JmjD2A-MO (+) and Control-MO (−) treated embryos.
Asterisk indicates P<0.05 versus control-MO by contingency table followed by chi-square.
Numbers represent individual embryos. See also Figure S5.
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Figure 5. Rescue experiment restored Sox10 expression
(A) Electroporation of JmjD2A morpholino (JmjD2A-MO, in green) together with a vector
containing the coding region of JmjD2A (JmjD2A-H2RFP, in red) rescues the depletion of
Sox10 expression as assayed by ISH. In contrast, co-electroporation JmjD2A-MO plus an
empty vector (H2RFP, in red) or catalytically-dead mutant of JmjD2A (ΔJmjD2A-H2RFP,
in red) failed to rescue the loss-of-function phenotype. (B) Quantitation of the numbers of
rescue experiment with either mild or strong phenotypes on the electroporated versus
contralateral side compared with those observed in control-MO treated embryos. Asterisk
indicates significant differences (P<0.01) by contingency table followed by chi-square test.
Numbers represent individual embryos. See also Figure S2.
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Figure 6. Dynamic changes in H3K9me3, H3K36me3 and JmjD2A occupancy on neural crest
specifier genes during chick development in vivo
(A) Chromatin immunoprecipiation (ChIP) assay was used to assess the H3K9me3 and
H3K36me3 occupancy around the transcriptional start site (TSS) of Sox10, Snail2 and β-
actin. Three independent experiments were performed for each stage. The vertical axis
represents % input (ChIP enriched/input) and horizontal axis the distance from the TSS in
kilobases (Kb). Schematic diagrams represent primer location over the three analyzed genes
and numbers represent approximate distance in Kb from the TSS. Cartoons schematize the
two stages (stages 4–5 and 10–11) of analysis, with red indicating the region of tissue
dissected and collected for ChIP. One representative sample is depicted per stage. The
results show high occupancy of H3K9me3 at −0.5kb from the TSS of Sox10 and Snail2
genes at stage 3–4. This repressive mark appears to be eliminated at stage 10–11. In
contrast, both Snail2 and β-actin genes shown high abundance of the active mark
H3K36me3, mostly downstream of the TSS. (B) ChIP assays assessed binding of JmjD2A at
-0.5Kb from the Sox10 and Snail2 TSS. The graphs show a mean ± SD of three independent
experiments for each stage. At stage 3–4, JmjD2A significantly binds to both Sox10
(0.006% input) and Snail2 (0.007% input), when compared with two distant, control regions
in their respective chromosome 1 (Chr1nc, 0.002% input) and 2 (Chr2nc, 0.003% input), as
well as with β-actin locus (0.003% input). At stage 10–11, this binding was greatly reduced
to 0.002 and 0.003% input on the Sox10 and Snail2 genes, respectively. Asterisk indicates
P<0.05 versus respective negative control by paired t-student test. See also Figure S6.
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Figure 7. JmjD2A activity is responsible for derepression of Sox10 by demethylating H3K9me3
ChIP was used to assay the occupancy of JmjD2A and H3K9me3 on the Sox10 gene from
stage 8 and 9 wild type or morpholinated embyos. Two to three independent experiments
were performed at each stage using 10 dorsal neural tubes per experiment. One
representative sample is depicted per stage. The graphs show a mean ± SD. (A) JmjD2A
occupancy at −0.5Kb from the TSS was high at stage 8 compared with a distant region in
the same chromosome (Chr1nc). By stage 9, however, this binding was greatly reduced to
values similar to those at Chr1nc. (B) Similarly, H3K9me3 occupancy at −0.5Kb from the
TSS was high at stage 8 but reduced by stage 9, reaching values similar to surrounding
positions (−1 and 0.5Kb from the TSS). (C) JmjD2A-MO completely abolished occupancy
of JmjD2A at stage 8, reaching values similar those observed on the negative control
Chr1nc. (D) In JmjD2A-MO treated embryos, H3K9me3 occupancy at stage 9 remained
high on the areas surrounding the TSS when compared with Control-MO treated embryos.
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